Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure

Abstract Kidney function is affected in COVID-19, while kidney itself modulates the immune response. Here, hypothesize if COVID-19 urine biomarkers level can assess immune activation vs. clinical trajectory. Considering the kidney’s critical role in modulating the immune response, we sought to analy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Krzysztof Laudanski, Tony Okeke, Hajj Jihane, Kumal Siddiq, Daniel J. Rader, Junnan Wu, Katalin Susztak
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/2248e4180117469d88cfa2a909ce1658
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2248e4180117469d88cfa2a909ce1658
record_format	dspace
spelling	oai:doaj.org-article:2248e4180117469d88cfa2a909ce16582021-12-02T16:56:43ZLongitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure10.1038/s41598-021-99102-52045-2322https://doaj.org/article/2248e4180117469d88cfa2a909ce16582021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99102-5https://doaj.org/toc/2045-2322Abstract Kidney function is affected in COVID-19, while kidney itself modulates the immune response. Here, hypothesize if COVID-19 urine biomarkers level can assess immune activation vs. clinical trajectory. Considering the kidney’s critical role in modulating the immune response, we sought to analyze activation markers in patients with pre-existing dysfunction. This was a cross-sectional study of 68 patients. Blood and urine were collected within 48 h of hospital admission (H1), followed by 96 h (H2), seven days (H3), and up to 25 days (H4) from admission. Serum level ferritin, procalcitonin, IL-6 assessed immune activation overall, while the response to viral burden was gauged with serum level of spike protein and αspike IgM and IgG. 39 markers correlated highly between urine and blood. Age and race, and to a lesser extend gender, differentiated several urine markers. The burden of pre-existing conditions correlated with urine DCN, CAIX and PTN, but inversely with IL-5 or MCP-4. Higher urinary IL-12 and lower CAIX, CCL23, IL-15, IL-18, MCP-1, MCP-3, MUC-16, PD-L1, TNFRS12A, and TNFRS21 signified non-survivors. APACHE correlated with urine TNFRS12, PGF, CAIX, DCN, CXCL6, and EGF. Admission urine LAG-3 and IL-2 predicted death. Pre-existing kidney disease had a unique pattern of urinary inflammatory markers. Acute kidney injury was associated, and to a certain degree, predicted by IFNg, TWEAK, MMP7, and MUC-16. Remdesavir had a more profound effect on the urine biomarkers than steroids. Urinary biomarkers correlated with clinical status, kidney function, markers of the immune system activation, and probability of demise in COVID-19.Krzysztof LaudanskiTony OkekeHajj JihaneKumal SiddiqDaniel J. RaderJunnan WuKatalin SusztakNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Krzysztof Laudanski Tony Okeke Hajj Jihane Kumal Siddiq Daniel J. Rader Junnan Wu Katalin Susztak Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
description	Abstract Kidney function is affected in COVID-19, while kidney itself modulates the immune response. Here, hypothesize if COVID-19 urine biomarkers level can assess immune activation vs. clinical trajectory. Considering the kidney’s critical role in modulating the immune response, we sought to analyze activation markers in patients with pre-existing dysfunction. This was a cross-sectional study of 68 patients. Blood and urine were collected within 48 h of hospital admission (H1), followed by 96 h (H2), seven days (H3), and up to 25 days (H4) from admission. Serum level ferritin, procalcitonin, IL-6 assessed immune activation overall, while the response to viral burden was gauged with serum level of spike protein and αspike IgM and IgG. 39 markers correlated highly between urine and blood. Age and race, and to a lesser extend gender, differentiated several urine markers. The burden of pre-existing conditions correlated with urine DCN, CAIX and PTN, but inversely with IL-5 or MCP-4. Higher urinary IL-12 and lower CAIX, CCL23, IL-15, IL-18, MCP-1, MCP-3, MUC-16, PD-L1, TNFRS12A, and TNFRS21 signified non-survivors. APACHE correlated with urine TNFRS12, PGF, CAIX, DCN, CXCL6, and EGF. Admission urine LAG-3 and IL-2 predicted death. Pre-existing kidney disease had a unique pattern of urinary inflammatory markers. Acute kidney injury was associated, and to a certain degree, predicted by IFNg, TWEAK, MMP7, and MUC-16. Remdesavir had a more profound effect on the urine biomarkers than steroids. Urinary biomarkers correlated with clinical status, kidney function, markers of the immune system activation, and probability of demise in COVID-19.
format	article
author	Krzysztof Laudanski Tony Okeke Hajj Jihane Kumal Siddiq Daniel J. Rader Junnan Wu Katalin Susztak
author_facet	Krzysztof Laudanski Tony Okeke Hajj Jihane Kumal Siddiq Daniel J. Rader Junnan Wu Katalin Susztak
author_sort	Krzysztof Laudanski
title	Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
title_short	Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
title_full	Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
title_fullStr	Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
title_full_unstemmed	Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
title_sort	longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/2248e4180117469d88cfa2a909ce1658
work_keys_str_mv	AT krzysztoflaudanski longitudinalurinarybiomarkersofimmunologicalactivationincovid19patientswithoutclinicallyapparentkidneydiseaseversusacuteandchronicfailure AT tonyokeke longitudinalurinarybiomarkersofimmunologicalactivationincovid19patientswithoutclinicallyapparentkidneydiseaseversusacuteandchronicfailure AT hajjjihane longitudinalurinarybiomarkersofimmunologicalactivationincovid19patientswithoutclinicallyapparentkidneydiseaseversusacuteandchronicfailure AT kumalsiddiq longitudinalurinarybiomarkersofimmunologicalactivationincovid19patientswithoutclinicallyapparentkidneydiseaseversusacuteandchronicfailure AT danieljrader longitudinalurinarybiomarkersofimmunologicalactivationincovid19patientswithoutclinicallyapparentkidneydiseaseversusacuteandchronicfailure AT junnanwu longitudinalurinarybiomarkersofimmunologicalactivationincovid19patientswithoutclinicallyapparentkidneydiseaseversusacuteandchronicfailure AT katalinsusztak longitudinalurinarybiomarkersofimmunologicalactivationincovid19patientswithoutclinicallyapparentkidneydiseaseversusacuteandchronicfailure
_version_	1718382729933881344

Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure

Ejemplares similares